Dr. Garret Wayne Choby, MD

Dr. Choby practices at University of Pittsburgh Physicians - HOPD in Pittsburgh, Pennsylvania.

Dr. Choby's NPI, 1407141799, was assigned on June 14, 2011. Dr. Choby graduated from Penn State College of Medicine in 2011. Dr. Choby holds Pennsylvania license 481439.

Dr. Choby's primary practice is University of Pittsburgh Physicians - HOPD, at 2 Hot Metal Street, Pittsburgh, PA 15203.

Dr. Choby's primary practice is University of Pittsburgh Physicians - HOPD in Pittsburgh, Pennsylvania. Dr. Choby is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Choby to 2 more hospitals, each named with a free account. Dr. Choby's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choby practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Choby's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Choby is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Choby's licenses on file in 4 states: Pennsylvania, California, Minnesota and Wisconsin.

Dmand AI lists chronic sinusitis, endoscopic sinus surgery and tinnitus among the conditions Dr. Choby treats.

CMS data shows 146 Medicare services from Dr. Choby across 5 procedure codes in 2024, for 73 Medicare patients. Medicare paid $20,139 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Choby in 2024. The largest group is 65 to 74, with 47 patients. 63% of them have high blood pressure, and 63% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Choby's median patient age at 65, with 46% women.

In 2024, Dr. Choby wrote 138 Medicare Part D claims for 62 patients. 99% of them were for generic drugs. CMS names the drug for 106 of them, across 5 drugs with 11 or more claims each, at $1,239 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Choby for performance year 2024, reported as part of a group. Dr. Choby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Choby as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 155 papers to Dr. Choby, published from 2012 to 2025. 2020 was the busiest year, with 27. The most frequent topics are Endoscopy, Skull Base and Rhinitis. Dr. Choby has published most often in Int Forum Allergy Rhinol. Dr. Choby's most frequent co-authors are Janalee Kae Stokken, MD, Eric Wesley Wang, MD and Erin K. O'Brien, MD.

Dmand AI links Dr. Choby to 1 clinical trial. Conditions studied include Pathological Conditions, Signs and Symptoms.

CMS Open Payments shows 29 general payments to Dr. Choby from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 75% of the total. Medtronic, Inc. paid the most, $782.

Dr. Choby graduated from Penn State College of Medicine in 2011. Dr. Choby is a member of AOA and NHS.

Dr. Choby is in network with 17 carriers, including Excellus BlueCross BlueShield, United Healthcare and HCSC. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.